Recombinant human hyaluronidase PH20 (rHuPH20) facilitates subcutaneous infusions of large volumes of immunoglobulin in a swine model

Many patients with primary immunodeficiency disease (PIDD) require lifelong immunoglobulin (Ig) replacement therapy. Home-based subcutaneous (SC) infusion provides advantages to patients with PIDD compared to hospital-based intravenous infusion. One limitation of current practice with SCIg infusion...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Drug delivery and translational research 2012-08, Vol.2 (4), p.254-264
Hauptverfasser:	Kang, David W., Jadin, Laurence, Nekoroski, Tara, Drake, Fred H., Zepeda, Monica L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical and Life Sciences Biomedicine Pharmaceutical Sciences/Technology Research Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!